Cost Effective

Direct Impact on Patient Management

Ammonia N-13 with CFR provides significant value to the overall management of coronary artery disease (CAD). Ammonia N-13 with CFR reduces unnecessary diagnostic procedures and can provide direction for both interventional and medical therapies. A study utilizing Ammonia N-13 with CFR demonstrated that the Ammonia N-13 CFR results had a direct impact on patient management in 78% of the patients while reducing the overall cost of managing coronary artery disease, even with an increase in the diagnostic imaging cost attributed to the Ammonia N-13 PET/CT study. 6

Patient Management graph showing Ammonia N-13 reduces unnecessary diagnostic procedures

6. Siegrist et al. “13N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness” Eur J Nucl Med Mol Imaging 2008; 35(5):889-895